Insider trades
Anzalone Christopher Richard, CEO of Arrowhead Pharmaceuticals ARWR, has filed 0 purchases and 49 sales on the open market. Over the past 12 months that comes to a net sale of $24M. The latest trade was on 01/02.
Anzalone Christopher Richard
CEO
- First filing
- 23/05/05
- Trades
- 69 trades
- Buys / sales
- 0 / 49
- 12-month net buying
- −$24M
- Last trade
- 01/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 01/02 | 01/05 | 13,187 sh2 trades | $66.10avg. | $871,702.77 | −0.3% | |
| Open-market sale10b5-1 plan | 25/12/29 | 25/12/30 | 51,726 sh2 trades | $69.13avg. | $3,575,574.78 | −1.3% | |
| Open-market sale10b5-1 plan | 25/12/19–25/12/22 | 25/12/23 | 26,031 sh5 trades | $68.04avg. | $1,771,022.38 | −0.7% | |
| Open-market sale | 25/12/17 | 25/12/19 | 85,000 sh4 trades | $64.04avg. | $5,443,462.11 | −2.2% | |
| Open-market sale | 25/12/15–25/12/16 | 25/12/16 | 184,298 sh12 trades | $67.00avg. | $12,348,801.97 | −4.5% | |
| Open-market sale | 25/04/09–25/04/11 | 25/04/11 | 141,122 sh5 trades | $10.87avg. | $1,533,336.57 | −3.5% | |
| Open-market sale | 25/03/13 | 25/03/17 | 51,425 sh | $15.07 | $774,974.75 | −1.3% | |
| Open-market sale10b5-1 plan | 25/03/03–25/03/04 | 25/03/05 | 300,000 sh2 trades | $17.58avg. | $5,274,333.67 | −7.4% | |
| Open-market sale10b5-1 plan | 25/01/02 | 25/01/06 | 11,520 sh | $19.05 | $219,456 | −0.3% | |
| Open-market sale10b5-1 plan | 24/12/23 | 24/12/23 | 12,563 sh | $19.59 | $246,109.17 | −0.3% | |
| Open-market sale10b5-1 plan | 24/12/18 | 24/12/20 | 26,712 sh3 trades | $21.24avg. | $567,485.84 | −0.7% | |
| Open-market sale10b5-1 plan | 24/01/31 | 24/02/02 | 57,499 sh2 trades | $32.35avg. | $1,860,019.34 | −1.5% | |
| Open-market sale10b5-1 plan | 24/01/02 | 24/01/04 | 9,952 sh2 trades | $31.01avg. | $308,636.66 | −0.3% | |
| Open-market sale10b5-1 plan | 23/12/20 | 23/12/22 | 12,000 sh | $28.54 | $342,480 | −0.3% | |
| Open-market sale10b5-1 plan | 23/10/25 | 23/10/27 | 24,338 sh | $24.21 | $589,222.98 | −0.6% | |
| Open-market sale | 23/09/18 | 23/09/20 | 57,755 sh2 trades | $28.12avg. | $1,624,222.64 | −1.5% | |
| Open-market sale | 23/05/03–23/05/04 | 23/05/05 | 104,928 sh3 trades | $39.32avg. | $4,125,673.52 | −2.7% |